|
Product Characteristics
Equimatrix® natural bone mineral matrix is a natural bone graft substitute derived from equine bone utilizing a unique purification process that removes all organic matter and ensures the highest level of safety for your patients.

The bone used to make Equimatrix® undergoes a series of rigorous heating and washing treatments that result in a consistently pure product.
Complex porous structure
The nano-crystalline surface of Equimatrix® seen under high power scanning electron microscopy has been demonstrated to have a high affinity for osteoblast cell attachment. Cellular attachment to the bone matrix is a critical precursor to successful regeneration of new bone.
 |
 |
 |
| Scanning electron microscopy at 700x |
Scanning electron microscopy at 2,500x |
Scanning electron microscopy at 50,000x |
Similarity to human bone
The complex, porous network found in Equimatrix® closely resembles natural human bone and results in excellent osteoconductive properties of the material.
 |
 |
| Equimatrix® |
Human bone |
Scientific Evidence: Canine Intrabony Defect Study1
Purpose
To evaluate the bone regenerative capacity of Equimatrix® in a canine intrabony defect model.
Methodology
Mandibular second an fourth premolars were extracted from 12 adult dogs;
- Periodontal probing depth was measured manually at the proximal sites of the mandibular third molar prior to defect creation.
- Two-walled intrabony defects (5x5x5 mm) were surgically created on the mesial and distal side of the mandibular third premolars
- The 48 defects were then randomly asigned into one of the following treatment groups:
- Equimatrix® plus Bio-Gide®
- Bio-Oss® plus Bio-Gide®
- Bio-Gide® only
- No treatment (control)
- Block sections and micro-CT scans of the defect sites were collected at 10, 16, 24 weeks after checking periodontal probing depth
Histomorphometric Results:


Results: Histologic Analysis
The intrabony defects in the control and membrane only (Bio-Gide®) groups showed mostly fibrous tissue with little evidence of new bone. In the Equimatrix® and Bio-Oss® groups, similar results were obtained in terms of new bone growth, remaining graft particles and connective tissue percentages.

| Equimatrix® + Bio-Gide® 40x |
Bio-Oss® + Bio-Gide® 40x |
 |
 |
|
Histologic view of Equimatrix®
at 24 weeks. Magnification 40x. (E=Equimatrix®; NB=new bone; NC=new cementum) |
Histologic view of Bio-Oss® at 24 weeks. Magnification 40x. (B=Bio-Oss®; NB=new bone; NC=new cementum) |
| Equimatrix® + Bio-Gide® 100x |
Bio-Oss® + Bio-Gide® 100x |
 |
 |
|
Histologic view of Equimatrix®
at 24 weeks. Magnification 100x. (E=Equimatrix®; NB=new bone; NC=new cementum; PDL=periodontal ligament) |
Histologic view of Bio-Oss®
at 24 weeks. Magnification 100x. (B=Bio-Oss®; NB=new bone; NC=new cementum; PDL=periodontal ligament) |
___________________ 1 Kim TI, Lee SC, Park YJ, Rhee SH, Chung CP. Experimental study on the bone regenerative capacity of equine bone mineral in canine alveolar bone defects. Journal of Periodontal & Implant Science 2011; 410 (5).
Bio-Oss and Bio-Gide are a registered trademarks of Ed. Geistlich Sohne Ag Fur Chemische. |